Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Saved in:
| Title: | Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1. |
|---|---|
| Authors: | Subbaramaiah K; Department of Medicine, Weill Cornell Cancer Center, New York, NY 10065, USA. ksubba@med.cornell.edu, Howe LR, Zhou XK, Yang P, Hudis CA, Kopelovich L, Dannenberg AJ |
| Source: | Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2012 Oct; Vol. 5 (10), pp. 1183-94. Date of Electronic Publication: 2012 Jul 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Retracted Publication |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
